You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: March 26, 2026

Drug Sales Trends for zinc sulfate


✉ Email this page to a colleague

« Back to Dashboard


Payment Methods and Pharmacy Types for zinc sulfate (2022)

Revenues by Pharmacy Type

Pharmacy Type Revenues
INSIDE HMO/CLINIC/HOSPITAL $8,078,648
DRUG STORE $606,413
[disabled in preview] $0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Units Sold by Pharmacy Type

Pharmacy Type Units
INSIDE HMO/CLINIC/HOSPITAL 11,932
DRUG STORE 64,489
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Revenues by Payment Method

Payment Method Revenues
MEDICAID $121,605
MEDICARE $203,927
[disabled in preview] $8,359,529
This preview shows a limited data set
Subscribe for full access, or try a Trial
Drug Sales Revenue Trends for zinc sulfate
Drug Units Sold Trends for zinc sulfate

Market Analysis and Sales Projections for Zinc Sulfate

Last updated: February 15, 2026

Zinc sulfate is a mineral supplement used primarily in agriculture, pharmaceuticals, and animal feed. Its demand is driven by the growing need for zinc-based medicinal therapies and the expansion of zinc application in agriculture to improve crop yield.


Market Size and Key Drivers

The global zinc sulfate market was valued at approximately $350 million in 2022. It is projected to reach around $490 million by 2028, with a compound annual growth rate (CAGR) of 5.7% over the forecast period (2023–2028) [1].

Key factors include:

  • Increasing zinc deficiency cases worldwide, fueling demand for dietary supplements.
  • Growing use in agriculture as a fertilizer additive to counter zinc-deficient soils.
  • Rising adoption in animal nutrition to improve livestock health.

Regional Market Distribution

North America held 35% of the market share in 2022, led by demand in the US and Canada. Asia-Pacific accounts for 40%, driven by India, China, and Southeast Asia's expanding agricultural sectors. Europe contributes 15%, with steady growth driven by pharmaceutical applications.


Market Segmentation

Application

  • Agriculture: 55%
  • Pharmaceuticals: 25%
  • Animal Feed: 15%
  • Others (cosmetics, chemical manufacturing): 5%

Form

  • Crystals: 45%
  • Powder: 40%
  • Granules: 15%

Distribution Channel

  • Direct sales: 60%
  • Distributors/retail: 40%

Sales Projections (2023–2028)

Year Estimated Market Revenue Growth Rate
2023 $370 million
2024 $393 million 6.1%
2025 $418 million 6.4%
2026 $445 million 6.4%
2027 $472 million 6.2%
2028 $490 million 3.8%

The slower growth rate in 2028 reflects market saturation in key regions and potential regulatory constraints.


Competitive Landscape

Major producers include Kempfen, Ozone International, and Aditya Birla Group. Market entry barriers involve compliance with pharmaceutical and agricultural standards. Pricing varies between $2 to $4 per kilogram, influenced by purity grade, form, and regional regulations.


Regulatory Environment

  • In the US, the FDA classifies zinc sulfate as Generally Recognized As Safe (GRAS) for food use.
  • The European Medicines Agency (EMA) regulates zinc sulfate as a medicinal product for zinc deficiency treatment.
  • Agricultural standards follow guidelines from the EPA, EU Fertilizer Regulation, and similar authorities, affecting manufacturing compliance and export potential.

Implications for Stakeholders

  • Manufacturers should focus on quality certifications (e.g., USP, FCC) to access pharmaceutical and food markets.
  • Distributors should build strong supply chains in emerging markets with zinc deficiency issues.
  • Investors may find growth opportunities in R&D for new formulations, particularly in animal health.

Key Takeaways

  • The zinc sulfate market is expanding at a steady CAGR, driven predominantly by agriculture and health sectors.
  • Asia-Pacific remains the largest regional market, with significant growth potential.
  • Market entrants must navigate regulatory standards across regions and emphasize product purity and safety.
  • Price strategies are influenced by form, target application, and regional factors.
  • Future growth hinges on increasing zinc deficiency awareness and regulatory approvals for new applications.

FAQs

1. What are the main factors influencing zinc sulfate sales?
Zinc deficiency prevalence, agricultural practices, pharmaceutical needs, and regulatory standards drive sales.

2. How does regional regulation affect market growth?
Regulatory compliance impacts manufacturing, export, and pricing, especially in pharmaceutical and agricultural sectors.

3. What is the outlook for zinc sulfate in animal nutrition?
It is a growing segment, accounting for 15% of the current market, with increasing focus on livestock health.

4. Are there notable R&D efforts in zinc sulfate?
Yes, innovations focus on improving bioavailability, purity, and new delivery formats for pharmaceuticals and supplements.

5. How do pricing strategies vary?
Prices fluctuate with product form, purity, applications, and regional regulations, generally ranging from $2 to $4 per kilogram.


Citations

[1] MarketsandMarkets, "Zinc Sulfate Market by Application, Form, and Region – Global Forecast to 2028," 2023.

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.